Cite
HARVARD Citation
Moschetti, V. et al. (n.d.). First‐in‐human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy males. British journal of clinical pharmacology. pp. 1315-1324. [Online].